Aurora Cannabis (ACB)
(Delayed Data from NSDQ)
$6.51 USD
+0.34 (5.51%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $6.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum B VGM
Price, Consensus and EPS Surprise
ACB 6.51 +0.34(5.51%)
Will ACB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ACB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ACB
Aurora Cannabis Inc. (ACB) Reports Q1 Loss, Tops Revenue Estimates
Stryker (SYK) Tops Q2 Earnings and Revenue Estimates
ACB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aurora Cannabis Inc. (ACB) Surpasses Q4 Earnings Estimates
High Tide Inc. (HITI) Reports Break-Even Earnings for Q2
Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates
Other News for ACB
Rising High: Clearmind granted patent approval for binge behavior treatment
Industrial Hemp's $14B Projected Growth: An Investment Opportunity Too Good To Miss
Rising High: Exclusive talk with psilocybin CPG brand PATOO
Medical Marijuana Patients In Germany Get Another Celebrity Offering With Wiz Khalifa's Cannabis Brand Coming Soon
Aurora Cannabis Receives Full Shareholder Backing at 2024 Meeting